Characterization of adsorbents for cytokine removal from blood in an in vitro model

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Harm, Stephan ^a,b   Gabor, Franz ^b   Hartmann, Jens ^a  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMBERCHROM CG161 M; DIVINYL BENZENE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IL6 PROTEIN, HUMAN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; POLYMER; POLYSTYRENE DERIVATIVE; SELE PROTEIN, HUMAN; TUMOR NECROSIS FACTOR; VINYL DERIVATIVE;

BIOLOGICAL MODEL; CHEMISTRY; CYTOLOGY; DEVICES; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; PARTICLE SIZE; SECRETION (PROCESS); SORPTION DETOXIFICATION; UMBILICAL VEIN ENDOTHELIAL CELL;

E-SELECTIN; GENE EXPRESSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MODELS, BIOLOGICAL; PARTICLE SIZE; POLYMERS; POLYSTYRENES; SORPTION DETOXIFICATION; TUMOR NECROSIS FACTOR-ALPHA; VINYL COMPOUNDS;

EID: 84953287464     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/484736     Document Type: Article

References (30)

1. T. van der Poll and S. J. H. van Deventer, "Cytokines and anticytokines in the pathogenesis of sepsis," Infectious Disease Clinics of North America, vol. 13, no. 2, pp. 413-426, 1999.
2. T. van der Poll, "Immunotherapy of sepsis,"TheLancet Infectious Diseases, vol. 1, no. 3, pp. 165-174, 2001.
3. L. G. Thijs and C. E. Hack, "Time course of cytokine levels in sepsis," Intensive CareMedicine, vol. 21, supplement 2, pp. S258-S263, 1995.
4. S. J. H. vanDeventer, H. R. Bller, J. W. tenGate, L. A. Aarden, C. E. Hack, and A. Sturk, "Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways," Blood, vol. 76, no. 12, pp. 2520-2526, 1990.
5. T. W. Rice and G. R. Bernard, "Therapeutic intervention and targets for sepsis," Annual Review of Medicine, vol. 56, pp. 225-248, 2005.
6. M. S. Rangel-Frausto, D. Pittet, M. Costigan, T. Hwang, C. S. Davis, and R. P. Wenzel, "The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study," The Journal of theAmericanMedical Association, vol. 273, no. 2, pp. 117-123, 1995.
7. R. Atan, D. Crosbie, and R. Bellomo, "Techniques of extracorporeal cytokine removal: a systematic review of the literature on animal experimental studies," The International Journal of Artificial Organs, vol. 36, no. 3, pp. 149-158, 2013.
8. M. Song, J. Winchester, R. L. Albright, V. J. Capponi, M. D. Choquette, and J. A. Kellum, "Cytokine removal with a novel adsorbent polymer," Blood Purification, vol. 22, no. 5, pp. 428-434, 2004.
9. J. D. Kimmel, G. A. Gibson, S. C. Watkins, J. A. Kellum, and W. J. Federspiel, "IL-6 adsorption dynamics in hemoadsorption beads studied using confocal laser scanning microscopy," Journal of Biomedical Materials Research-Part B: Applied Biomaterials, vol. 92, no. 2, pp. 390-396, 2010.
10. T. Rimmel?, A. M. Kaynar, J. N. McLaughlin, et al., "Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study," Critical Care, vol. 17, articleR59, 2013.
11. C. Ronco, A. Brendolan, G. Lonnemann, et al., "A pilot study of coupled plasma filtration with adsorption in septic shock," Critical Care Medicine, vol. 30, no. 6, pp. 1250-1255, 2002.
12. R. Sykora, J. Chvojka, A. Krouzecky, et al., "Coupled plasma filtration adsorption in experimental peritonitis-induced septic shock," Shock, vol. 31, no. 5, pp. 473-480, 2009.
13. R. Abdul Cader, H. Abdul Gafor, R. Mohd, W. Yen Kong, N. Arshad, and N. Kong, "Coupled plasma filtration and adsorption (CPFA): a single center experience," Nephro-Urology Monthly, vol. 5, no. 4, pp. 891-896, 2013.
14. S. Livigni, G. Bertolini, C. Rossi, et al., "Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial," BMJ Open, vol. 4, no. 1, Article ID e003536, 2014.
15. S. Harm, D. Falkenhagen, and J. Hartmann, "Pore size-a key property for selective toxin removal in blood purification," The International Journal of Artificial Organs, vol. 37, no. 9, pp. 668-678, 2014.
16. M. Al-Bokari, D. Cherrak, and G. Guiochon, "Determination of the porosities of monolithic columns by inverse size-exclusion chromatography," Journal of Chromatography A, vol. 975, no. 2, pp. 275-284, 2002.
17. Y. Yao and A. M. Lenhoff, "Determination of pore size distributions of porous chromatographic adsorbents by inverse sizeexclusion chromatography," Journal of Chromatography A, vol. 1037, no. 1-2, pp. 273-282, 2004.
18. M. Leonard, C. Fournier, and E. Dellacherie, "Polyvinyl alcoholcoated macroporous polystyrene particles as stationary phases for the chromatography of proteins," Journal of Chromatography B: Biomedical Sciences and Applications, vol. 664, no. 1, pp. 39-46, 1995.
19. D. Venturoli and B. Rippe, "Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability," American Journal of Physiology-Renal Physiology, vol. 288, no. 4, pp. F605-F613, 2005.
20. V. Marin, G. Kaplanski, S. Gres, C. Farnarier, and P. Bongrand, "Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells," Journal of Immunological Methods, vol. 254, no. 1-2, pp. 183-190, 2001.
21. F. A. Bozza, J. I. Salluh, A. M. Japiassu, et al., "Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis," Critical Care, vol. 11, article R49, 2007.
22. T. S. Blackwell and J. W. Christman, "Sepsis and cytokines: current status," British Journal of Anaesthesia, vol. 77, no. 1, pp. 110-117, 1996.
23. W. Schulte, J. Bernhagen, and R. Bucala, "Cytokines in sepsis: potent immunoregulators and potential therapeutic targets-an updated view," Mediators of Inflammation, vol. 2013, Article ID 165974, 16 pages, 2013.
24. L. Vroman, "Effect of adsorbed proteins on the wettability of hydrophilic and hydrophobic solids," Nature, vol. 196, no. 4853, pp. 476-477, 1962.
25. J. Boisram?-Helms, H. Kremer, V. Schini-Kerth, and F. Meziani, "Endothelial dysfunction in sepsis," Current Vascular Pharmacology, vol. 11, no. 2, pp. 150-160, 2013.
26. R. Rothlein, M. L. Dustin, S. D. Marlin, and T. A. Springer, "A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1,"TheJournal of Immunology, vol. 137, no. 4, pp. 1270-1274, 1986.
27. G. Kleiner, A. Marcuzzi, V. Zanin, L. Monasta, and G. Zauli, "Cytokine levels in the serum of healthy subjects," Mediators of Inflammation, vol. 2013, Article ID 434010, 6 pages, 2013.
28. V. Mak?, J. Cz?cz, Z. Weiszhr, et al., "Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1beta, TNF-alpha, and LPS," Cytometry Part A, vol. 77, no. 10, pp. 962-970, 2010.
29. V.M. Elner,W. Scales, S. G. Elner, J. Danforth, S. L.Kunkel, and R. M. Strieter, "Interleukin-6 (IL-6) gene expression and secretion by cytokine-stimulated human retinal pigment epithelial cells, " Experimental Eye Research, vol. 54, no. 3, pp. 361368, 1992.
30. T. Rimmel? and J. A. Kellum, "Clinical review: blood purification for sepsis," Critical Care, vol. 15, no. 1, article 205, 2011.